180 Life Sciences Corp.
11.02
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About 180 Life Sciences Corp.
180 Life Sciences Corp. es una empresa constituida conforme a las leyes del estado de Delaware el 7 de septiembre de 2016. Se trata de una compañía biotecnológica en fase clínica, dedicada al desarrollo de nuevos medicamentos que buscan satisfacer necesidades no cubiertas en el tratamiento de enfermedades inflamatorias, fibrosis y dolor. Su sede se encuentra en 3000 El Camino Real, Edificio 4, Suite 200, Palo Alto, CA 94306. Para más información, visite su sitio web: http://www.180lifesciences.com
Trade GPT
Similar Stocks
© 2025 Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.
Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.